To study this possibility, we analyzed the expression of MERIT40 in 499 breast tumors (Curie cohort) classified into four subtypes according to their hormone receptors (ER/PR) and ERBB2 status (see Materials and Methods) (Table 1). This evidence concerns the gene ESR1 and breast neoplasm.